See also this year's filing and all EDGAR filings for this company.
PDF Report 0001743881_2021_Bridgebio_Pharma_Inc.pdf
Logs
| warning | Large missing amount for aggregate "Liabilities" added to remainder. | industry.us_generic | {'missing_ratio': 2.103114396069504, 'aggregate_val': 1878371000, 'exp_sum': 605318000, 'exp_to_value': {'LiabilitiesCurrent': 135069000, 'LiabilitiesNoncurrent': 470249000, 'remainder_Liabilities': 0}} |
Graph
Absolute values for 0001743881, Bridgebio Pharma Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 642,824,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 20,325,000 |
| 3 | remainder_Assets | 40,439,000 |
| 4 | LiabilitiesCurrent | 95,648,000 |
| 5 | LiabilitiesNoncurrent | 116,618,000 |
| 6 | remainder_Liabilities | 383,436,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 145,684,000 |
| 9 | ResearchAndDevelopmentExpense | 337,047,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 8,249,000 |
| 12 | remainder_NetIncome | -31,006,000 |
| 13 | remainder_ComprehensiveNetIncome | 56,702,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 703,588,000 |
| 1 | Liabilities | 595,702,000 |
| 2 | Expenses | 482,731,000 |
| 3 | Revenues | 8,249,000 |
| 4 | StockholdersEquity | 107,886,000 |
| 5 | NetIncome | -505,488,000 |
| 6 | ComprehensiveNetIncome | -477,137,000 |
| 7 | BaseVar | 938,989,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.372 |
| 9 | EconomicCapitalRatio | 1.39 |
Edgar->Model Mapping
Feature Distribution
Change over Time
